Variant report
Variant | nsv553854 |
---|---|
Chromosome Location | chr11:25086509-25175198 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:157)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BHLHE40 | chr11:25158684-25158720 | GM12878 | blood: | n/a | n/a |
2 | CEBPB | chr11:25141487-25142080 | Hela-S3 | cervix: | n/a | chr11:25141910-25141921 |
3 | CEBPB | chr11:25172862-25173040 | HepG2 | liver: | n/a | n/a |
4 | CEBPB | chr11:25159359-25159440 | K562 | blood: | n/a | chr11:25159402-25159413 |
5 | CEBPB | chr11:25115693-25115948 | HepG2 | liver: | n/a | n/a |
6 | CEBPB | chr11:25141454-25142097 | IMR90 | lung: | n/a | chr11:25141910-25141921 |
7 | CEBPB | chr11:25115739-25115908 | HepG2 | liver: | n/a | n/a |
8 | CEBPB | chr11:25141770-25142081 | HepG2 | liver: | n/a | chr11:25141910-25141921 |
9 | CEBPB | chr11:25087024-25087563 | Hela-S3 | cervix: | n/a | n/a |
10 | CEBPB | chr11:25141777-25142021 | A549 | lung: | n/a | chr11:25141910-25141921 |
11 | CEBPB | chr11:25086865-25087560 | IMR90 | lung: | n/a | n/a |
12 | CEBPB | chr11:25172819-25173060 | A549 | lung: | n/a | n/a |
13 | CTCF | chr11:25152725-25152848 | NHEK | skin: | n/a | n/a |
14 | CTCF | chr11:25086730-25086802 | GM10248 | blood: | n/a | n/a |
15 | CTCF | chr11:25152740-25152890 | WERI-Rb-1 | eye: | n/a | n/a |
16 | CTCF | chr11:25152720-25152870 | SK-N-SH_RA | brain: | n/a | n/a |
17 | CTCF | chr11:25150541-25150617 | GM20000 | blood: | n/a | n/a |
18 | CTCF | chr11:25152746-25152799 | Hela-S3 | cervix: | n/a | n/a |
19 | CTCF | chr11:25132267-25132303 | GM13976 | blood: | n/a | n/a |
20 | CTCF | chr11:25126821-25126900 | GM10248 | blood: | n/a | n/a |
21 | E2F4 | chr11:25087027-25087420 | MCF10A-Er-Src | breast: | n/a | n/a |
22 | E2F4 | chr11:25121106-25121305 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | EP300 | chr11:25087327-25087423 | GM12878 | blood: | n/a | n/a |
24 | EP300 | chr11:25087181-25087560 | Hela-S3 | cervix: | n/a | chr11:25087448-25087455 |
25 | FAM48A | chr11:25119491-25119534 | GM12878 | blood: | n/a | n/a |
26 | FOS | chr11:25089951-25090447 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | FOS | chr11:25133275-25133475 | HUVEC | blood vessel: | n/a | n/a |
28 | FOS | chr11:25087146-25087610 | HUVEC | blood vessel: | n/a | chr11:25087349-25087361 chr11:25087351-25087359 chr11:25087205-25087219 chr11:25087411-25087422 |
29 | FOS | chr11:25089964-25090338 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | FOS | chr11:25116602-25116607 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | FOS | chr11:25089929-25090500 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | FOS | chr11:25086817-25087747 | MCF10A-Er-Src | breast: | n/a | chr11:25087349-25087361 chr11:25087351-25087359 chr11:25087205-25087219 chr11:25087411-25087422 |
33 | FOS | chr11:25087052-25087651 | MCF10A-Er-Src | breast: | n/a | chr11:25087349-25087361 chr11:25087351-25087359 chr11:25087205-25087219 chr11:25087411-25087422 |
34 | FOS | chr11:25087201-25087573 | Hela-S3 | cervix: | n/a | chr11:25087349-25087361 chr11:25087351-25087359 chr11:25087205-25087219 chr11:25087411-25087422 |
35 | FOS | chr11:25117043-25117216 | MCF10A-Er-Src | breast: | n/a | n/a |
36 | FOS | chr11:25087079-25087650 | MCF10A-Er-Src | breast: | n/a | chr11:25087349-25087361 chr11:25087351-25087359 chr11:25087205-25087219 chr11:25087411-25087422 |
37 | FOS | chr11:25089954-25090430 | MCF10A-Er-Src | breast: | n/a | n/a |
38 | FOS | chr11:25086891-25087668 | MCF10A-Er-Src | breast: | n/a | chr11:25087349-25087361 chr11:25087351-25087359 chr11:25087205-25087219 chr11:25087411-25087422 |
39 | FOSL2 | chr11:25087225-25087538 | A549 | lung: | n/a | chr11:25087349-25087361 chr11:25087351-25087359 |
40 | FOSL2 | chr11:25087181-25087620 | SK-N-SH | brain: | n/a | chr11:25087349-25087361 chr11:25087351-25087359 chr11:25087205-25087219 |
41 | FOSL2 | chr11:25087160-25087570 | MCF-7 | breast: | n/a | chr11:25087349-25087361 chr11:25087351-25087359 chr11:25087205-25087219 |
42 | FOSL2 | chr11:25087099-25087604 | MCF-7 | breast: | n/a | chr11:25087349-25087361 chr11:25087351-25087359 chr11:25087205-25087219 |
43 | FOSL2 | chr11:25087131-25087660 | A549 | lung: | n/a | chr11:25087349-25087361 chr11:25087351-25087359 chr11:25087205-25087219 |
44 | FOXA1 | chr11:25115661-25115991 | HepG2 | liver: | n/a | n/a |
45 | GATA3 | chr11:25087033-25087740 | A549 | lung: | n/a | chr11:25087178-25087188 chr11:25087349-25087358 |
46 | GATA3 | chr11:25087109-25087728 | SK-N-SH | brain: | n/a | chr11:25087178-25087188 chr11:25087349-25087358 |
47 | GATA3 | chr11:25111593-25111833 | SH-SY5Y | brain: | n/a | n/a |
48 | GATA3 | chr11:25087221-25087673 | SK-N-SH | brain: | n/a | chr11:25087349-25087358 |
49 | GATA3 | chr11:25141679-25141875 | SH-SY5Y | brain: | n/a | n/a |
50 | GATA3 | chr11:25087027-25087637 | MCF-7 | breast: | n/a | chr11:25087178-25087188 chr11:25087349-25087358 |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:25134241..25135929-chr11:25140334..25142884,3 | K562 | blood: | |
2 | chr11:25131462..25133230-chr11:25136109..25137938,2 | MCF-7 | breast: | |
3 | chr11:25134241..25135929-chr11:25140334..25142884,3 | K562 | blood: | |
4 | chr11:25131462..25133230-chr11:25136109..25137938,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000255368 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs139835341 | chr11:25086621-25086622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs192273627 | chr11:25086625-25086626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs1446163 | chr11:25086653-25086654 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs564759099 | chr11:25086661-25086662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs1446162 | chr11:25086664-25086665 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs116912762 | chr11:25086677-25086678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs372098129 | chr11:25086680-25086681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs563902861 | chr11:25086684-25086685 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs529393500 | chr11:25086753-25086754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs549539629 | chr11:25086762-25086763 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs1446161 | chr11:25086768-25086769 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs183251792 | chr11:25086810-25086811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs551494901 | chr11:25086811-25086812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs571488802 | chr11:25086815-25086816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs562076736 | chr11:25086828-25086829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs556721260 | chr11:25086832-25086833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs577475182 | chr11:25086864-25086865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs371427325 | chr11:25086870-25086871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs187832832 | chr11:25086902-25086903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs552983659 | chr11:25086917-25086918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs538398660 | chr11:25086918-25086919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs544952935 | chr11:25086919-25086920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs558291969 | chr11:25086941-25086942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs7122480 | chr11:25087004-25087005 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs544164023 | chr11:25087017-25087018 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs145458676 | chr11:25087030-25087031 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs144262639 | chr11:25087042-25087043 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs148468156 | chr11:25087050-25087051 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs77238145 | chr11:25087060-25087061 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs142612814 | chr11:25087064-25087065 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs1992732 | chr11:25087092-25087093 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs527481868 | chr11:25087096-25087097 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs530705648 | chr11:25087110-25087111 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs373447506 | chr11:25087140-25087141 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs76666474 | chr11:25087207-25087208 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs1992731 | chr11:25087232-25087233 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs376787254 | chr11:25087239-25087240 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs567224205 | chr11:25087250-25087251 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs535999573 | chr11:25087256-25087257 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs143457538 | chr11:25087264-25087265 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs546045927 | chr11:25087269-25087270 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs374245733 | chr11:25087276-25087277 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs566535519 | chr11:25087277-25087278 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs538386286 | chr11:25087285-25087286 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs564810345 | chr11:25087350-25087351 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs112265617 | chr11:25087381-25087382 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs575355125 | chr11:25087405-25087406 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs537738000 | chr11:25087411-25087412 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs549421171 | chr11:25087441-25087442 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs146669280 | chr11:25087442-25087443 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Potocki-Shaffer syndrome | 19222835 | CNVD |
WAGR syndrome | 19222835 | CNVD |
Chordoma | 18071362 | CNVD |
Autism | 22102821 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:25086600-25087000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
2 | chr11:25086800-25088000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
3 | chr11:25086800-25088400 | Enhancers | Hela-S3 | cervix |
4 | chr11:25086800-25088600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr11:25086800-25088600 | Enhancers | NHEK | skin |
6 | chr11:25087000-25088600 | Enhancers | NH-A | brain |
7 | chr11:25087000-25091200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
8 | chr11:25087600-25088200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
9 | chr11:25088600-25090000 | Weak transcription | NHEK | skin |
10 | chr11:25088600-25090200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
11 | chr11:25089800-25090600 | Enhancers | HMEC | breast |
12 | chr11:25090000-25090600 | Enhancers | NHEK | skin |
13 | chr11:25090200-25090600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
14 | chr11:25115000-25115600 | Enhancers | Liver | Liver |
15 | chr11:25115600-25115800 | Flanking Active TSS | Liver | Liver |
16 | chr11:25115800-25116200 | Enhancers | Liver | Liver |